VERRICA PHARMACEUTICALS INC

$3.91 0.00% ($0.00)

Get ready to invest

About VERRICA PHARMACEUTICALS INC

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. The Company's lead product candidate, VP-102, is a drug-device combination of its topical solution of cantharidin, a widely recognized, naturally sourced agent to treat topical dermatological conditions, administered through its single-use precision applicator. It is developing VP-102 for the treatment of molluscum contagiosum (molluscum), a highly contagious and primarily pediatric viral skin disease, external genital warts and common warts. It also intends to develop its second cantharidin-based product candidate, VP-103, for the treatment of plantar warts, which are warts located on the bottom of the foot. It also intends to develop its third product candidate, LTX-315, for the treatment of dermatological oncology indications, including non-metastatic melanoma and non-metastatic Merkel cell carcinoma.

Popular Stocks	Price	Change
Nu Holdings NU	$4.68 10.12%	10.12%
AMC AMC	$24.21 0.94%	0.94%
AMD AMD	$101.01 0.18%	0.18%
Nvidia NVDA	$190.32 1.73%	1.73%
Invitae NVTA	$5.01 6.7%	6.7%
Snap SNAP	$12.24 5.34%	5.34%
Bed Bath & Beyond BBBY	$16 23.55%	23.55%
Ford F	$16.32 0.87%	0.87%
Apple AAPL	$173.19 0.63%	0.63%
Petróleo Brasileiro S.A. PBR	$13.68 0.44%	0.44%